High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy: V. Validation of a direct injection/on-line guard cartridge extraction–tandem mass spectrometry method for CYP1A2 inhibition assessment
Authors:
- 28 February 2001
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 12 (4) , 447-452
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. I. Development of direct injection/on-line guard cartridge extraction/tandem mass spectrometry for the simultaneous detection of CYP probe substrates and their metabolitesRapid Communications in Mass Spectrometry, 2000
- High-throughput Caco-2 cell permeability screening by cassette dosing and sample pooling approaches using direct injection/on-line guard cartridge extraction/tandem mass spectrometryRapid Communications in Mass Spectrometry, 2000
- Determination of a ‘GW cocktail’ of cytochrome P450 probe substrates and their metabolites in plasma and urine using automated solid phase extraction and fast gradient liquid chromatography tandem mass spectrometryRapid Communications in Mass Spectrometry, 1999
- Cellular localization of hepatic cytochrome 1B1 expression and its regulation by aromatic hydrocarbons and inflammatory cytokinesBiochemical Pharmacology, 1999
- Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potentialXenobiotica, 1999
- Interlaboratory comparison of the assessment of P450 activities in human hepatic microsomal samplesXenobiotica, 1998
- Validation of the five-drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug-metabolizing enzymes*Clinical Pharmacology & Therapeutics, 1997
- Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cellsCarcinogenesis, 1997
- Expression of CYP1A1 and CYP1A2 genes in human liverPharmacogenetics, 1993
- Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.British Journal of Clinical Pharmacology, 1990